Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 2, 2012, Pages 420-427

  Huang, Yi Ting ^a   Wang, Chun Chieh ^a   Tsai, Chien Sheng ^a   Lai, Chyong Huey ^a   Chang, Ting Chang ^a   Chou, Hung Hsueh ^a   Lee, Steve P ^b   Hong, Ji Hong ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenocarcinoma adenosquamous carcinoma; Cervical cancer; Concurrent chemoradiotherapy; Postoperative radiotherapy; Radical hysterectomy

Indexed keywords

ADENOCARCINOMA/ADENOSQUAMOUS CARCINOMA; CERVICAL CANCERS; CONCURRENT CHEMORADIOTHERAPY; POSTOPERATIVE RADIOTHERAPY; RADICAL HYSTERECTOMY;

CHEMORADIOTHERAPY; GYNECOLOGY; HISTOLOGY; PATIENT MONITORING; RADIOTHERAPY;

PATHOLOGY;

CISPLATIN; PACLITAXEL;

ADENOSQUAMOUS CARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; TREATMENT FAILURE; TREATMENT OUTCOME; UTERINE CERVIX ADENOSQUAMOUS CARCINOMA; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PACLITAXEL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT FAILURE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84865632475     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.12.013     Document Type: Article

References (14)

1. H.O. Smith, M.F. Tiffany, and C.R. Qualls The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States - a 24-year population-based study Gynecol Oncol 78 2000 97 105
2. P. Sasieni, and J. Adams Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England Lancet 357 2001 1490 1493
3. P.J. Eifel, T.W. Burke, and M. Morris Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma Gynecol Oncol 59 1995 38 44
4. C.H. Lai, S. Hsueh, and J.H. Hong Are adenocarcinomas and adenosquamous carcinomas different from squamous carcinomas in Stage IB and II cervical cancer patients undergoing primary radical surgery? Int J Gynecol Cancer 9 1999 28 36
5. J.H. Hong, C.S. Tsai, and C.C. Wang Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/ adenosquamous carcinomas of the cervix Chang Gung Med J 23 2000 396 404
6. Y.T. Huang, C.C. Wang, and C.S. Tsai Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy Int J Radiat Oncol Biol Phys 80 2011 429 436
7. G.C. Alfsen, G.B. Kristensen, and E. Skovlund Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: A population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix Cancer 92 2001 2471 2483
8. F. Landoni, A. Maneo, and A. Colombo Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer Lancet 350 1997 535 540
9. W.A. Peters 3rd, P.Y. Liu, and R.J. Barrett 2nd Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
10. C.S. Tsai, C.H. Lai, and C.C. Wang The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy Gynecol Oncol 75 1999 328 333
11. J.H. Hong, C.S. Tsai, and C.H. Lai Postoperative low-pelvic irradiation for stage I-IIA cervical cancer patients with risk factors other than pelvic lymph node metastasis Int J Radiat Oncol Biol Phys 53 2002 1284 1290
12. Y. Niibe, M. Kenjo, and H. Onishi High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: A multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 Jpn J Clin Oncol 40 2010 795 799
13. H.H. Chou, H.P. Chang, and C.H. Lai 18F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma Eur J Nucl Med Mol Imaging 37 2010 728 735
14. J.P. Curtin, J.A. Blessing, and K.D. Webster Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: A Gynecologic Oncology Group Study J Clin Oncol 20 2002 966 972